Breaking News

Tweet TWEET

FDA REVIEW OF SANOFI’S LEMTRADA IN MULTIPLE SCLEROSIS

The following is a reformatted version of a press release issued
by The FDA and obtained from www.fda.gov.
 
 
Press spacebar to pause and continue. Press esc to stop.